UPMC Executive Chosen for International Health Care Leadership Award

By: Wendy Zellner

The National Center for Healthcare Leadership (NCHL) has selected UPMC International President Charles Bogosta for its 2022 International Healthcare Leadership Award. The honor recognizes Bogosta for leading UPMC’s efforts for more than 15 years to share its clinical, managerial and technological expertise to improve the health of patients around the world.

“Mr. Bogosta is a champion of expanding global access to U.S. expertise in health care,” said LeAnn Swanson, chief executive officer of NCHL. “Given that NCHL’s mission and work are dedicated to advancing health care leadership and organizational excellence by building diverse, inclusive and collaborative relationships in the U.S. and abroad, we are thrilled to honor a leader whose vision has helped transform UPMC into a truly integrated, global health care system that is committed to providing high-quality care to patients around the world.”

UPMC has long held a unique place among U.S. health care institutions operating in international markets. Since the 1997 launch of UPMC’s transplant hospital, ISMETT, in partnership with the Region of Sicily, UPMC has taken a distinctive approach as an overseas operator of hospitals and cancer centers by owning and managing facilities, employing physicians and staff, and making long-term investments to keep patients close to home for care. UPMC followed the success of ISMETT with dozens of international ventures before recently concentrating its efforts in Italy, Ireland, China and Kazakhstan.

“This honor is a testament to the hard work and dedication of the UPMC International team and to all of the UPMC employees and clinicians who have supported us over the years,” said Bogosta. “Our efforts have not only improved care for thousands of patients in the countries we serve but have also supported the fundamental medical and research missions of UPMC. Our international operations and partners have been instrumental in helping us to attract the most talented clinicians and researchers, to reinvest in cutting-edge medicine, and to boost the global reputation of UPMC and of Pittsburgh.”

Bogosta, who will be honored at the NCHL All-Member Conference in Chicago on Nov. 15, joined UPMC in 1997 and previously served as president of UPMC Hillman Cancer Center, where he remains vice chairman of its board of directors.

With a staff of more than 2,000 people across its operations, UPMC International has developed ISMETT into one of the leading transplant and high-specialty centers in all of Europe, opened advanced radiotherapy centers and hospitals in Italy and Ireland, begun preparations for the creation of an academic medical center in Kazakhstan, and laid the groundwork for the opening of the first major hospital in China to be managed by a leading American academic medical center.